首頁 > 市場調查報告書 > 製藥

感染疾病

市場調查報告書

商品編碼

2058394

阿米巴病治療市場：按藥物類型、分銷管道和地區分類

Amebiasis Treatment Market, By Drug Type, By Distribution Channel, By Geography

出版日期: 2026年05月04日 | 出版商:

Coherent Market Insights | 英文 153 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2026年阿米巴病治療市場規模估計為12億美元，預計2033年將達22億美元。預計從2026年到2033年，該市場將以6.3%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	12億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	6.30%	2033年市場規模預測：	22億美元

該市場正經歷著顯著的變革，其主要驅動力在於人們對寄生蟲感染疾病的認知不斷提高、診斷能力的提升以及對有效抗阿米巴療法的需求日益成長。阿米巴感染主要由溶組織內阿米巴引起，主要影響胃腸道，如不及時治療，可導致嚴重的併發症，例如阿米巴結腸炎和肝膿瘍。該市場涵蓋多種治療方案，包括硝基咪唑類藥物、腸道療法、聯合治療和輔助治療產品。

醫療專業人員越來越重視早期診斷和標靶治療，以減少疾病傳播並預防復發。糞便抗原檢測、分子診斷和影像技術的進步提高了病例檢出率，尤其是在衛生條件差、醫療資源有限的高發病率地區。此外，聯合治療的廣泛應用能夠同時清除侵襲性滋養體和腸道包囊，從而改善治療效果並降低復發風險。

市場動態

由於溶組織內阿米巴（組織阿米巴）引起的腸內和腸外感染疾病持續肆虐，阿米巴病治療市場呈現強勁成長動能。市場成長的主要驅動力是人們對有效抗阿米巴病療法的需求不斷增加，尤其是在熱帶地區和衛生條件較差、感染風險仍然很高的地區。抗生素和抗寄生蟲藥物在疾病管理中發揮核心作用，有助於緩解腹瀉、腹痛和侵襲性併發症等症狀。對早期診斷的日益重視、治療可及性的提高以及公眾健康意識的增強，都進一步推動了對可靠阿米巴病治療方法的需求。

醫療基礎設施的擴張在推動市場成長方面發揮核心作用。這一成長主要得益於診斷檢測的普及、醫生認知水平的提高以及甲硝唑、替硝唑、Paromomycin和糠酸二氯尼特等處治療方法的可及性增強。治療方案通常包括使用組織活化劑治療侵襲性疾病，隨後使用腔內藥物清除腸道內的囊腫，徹底控制感染並降低感染復發和擴散的風險。

對有效感染疾病控制日益成長的需求也推動了阿米巴病治療市場的成長。以衛生、安全飲用水、食品安全和寄生蟲控制為重點的公共衛生計畫增加了對及時治療方案的需求。醫院、診所、實驗室、藥房和公共衛生機構在識別和管理阿米巴病病例方面發揮著至關重要的作用。隨著人們對寄生蟲感染疾病的認知不斷提高，預計市場將受益於治療途徑的改善、患者遵守用藥的提高以及更安全、更具針對性的抗阿米巴藥物方案的研發。

本研究的主要特點：

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對阿米巴感染治療市場的主要參與者進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
阿米巴病治療市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過分析阿米巴病治療市場中使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第7章競爭情勢

熱圖分析
市佔率分析
公司簡介
- Pfizer Inc.
- Impax Laboratories,
- Lupin Pharmaceuticals, Inc.
- Sanofi
- Actelion Pharmaceuticals Ltd.
- Glenmark Pharmaceuticals
- Sun Pharmaceutical Industries Inc.
- Heritage Pharmaceuticals Inc.
- Mission Pharmacal Co.
- Novel Laboratories

第8章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI1595

Amebiasis Treatment Market is estimated to be valued at USD 1,200 Mn in 2026 and is expected to reach USD 2,200 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.3% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 1,200 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.30%	2033 Value Projection:	USD 2,200 Mn

The market is undergoing a major transformation mainly driven by rising awareness of parasitic infections, improved diagnostic capabilities, and growing demand for effective anti-amoebic therapies. Amebiasis, primarily caused by Entamoeba histolytica, affects the intestinal tract and may lead to severe complications like amoebic colitis and liver abscess if left untreated. The market includes a wide array of treatment options like nitroimidazole-based drugs, luminal agents, combination therapies, and supportive care products.

The healthcare providers are increasingly focusing on early diagnosis and targeted treatment to reduce disease transmission and prevent recurrence. The advancements in stool antigen testing, molecular diagnostics, and imaging techniques are improving case detection, especially in high-burden regions with poor sanitation and limited healthcare access. In addition, the growing use of combination therapy helps eliminate both invasive trophozoites as well as intestinal cysts, thereby improving treatment outcomes and lowering relapse risk.

Market Dynamics

The amebiasis treatment market is witnessing a major momentum owing to the continued burden of intestinal and extra-intestinal infections caused by Entamoeba histolytica. The market's growth is largely attributed to the growing need for effective anti-amoebic therapies, especially in tropical and low-sanitation regions where the risk of infection remains higher. Antibiotics and antiparasitic drugs play a central role in disease management, thereby helping reduce symptoms like diarrhea, abdominal pain, and invasive complications. The rising focus on early diagnosis, improved access to treatment, and public health awareness is strengthening the demand for reliable amebiasis treatment options.

The expansion of healthcare infrastructure plays a central role in stimulating the market's growth. This growth is mainly driven by the increasing adoption of diagnostic testing, improved physician awareness, and wider availability of prescription-based therapies like metronidazole, tinidazole, paromomycin, iodoquinol, and diloxanide furoate. The treatment protocols often involve tissue-active drugs for invasive disease followed by luminal agents to clear intestinal cysts, which supports complete infection management and reduces the risk of recurrence or transmission.

The rising demand for effective infectious disease control is also responsible for the growth of the amebiasis treatment market. Public health programs focused on sanitation, safe drinking water, food hygiene, and parasite control are creating a stronger need for timely treatment solutions. Hospitals, clinics, diagnostic laboratories, retail pharmacies, and public health agencies play a crucial role in identifying and managing amebiasis cases. As awareness of parasitic infections increases, the market is expected to benefit from improved treatment access, better patient compliance, and the development of safer and more targeted anti-amoebic drug regimens.

Key Features of the Study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the amebiasis treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer Inc., Impax Laboratories, Lupin Pharmaceuticals, Inc., Sanofi, Actelion Pharmaceuticals Ltd., Glenmark Pharmaceuticals, Sun Pharmaceutical Industries Inc., Heritage Pharmaceuticals Inc., Mission Pharmacal Co., Novel Laboratories, and others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The Amebiasis Treatment Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Amebiasis Treatment Market

Market Segmentation

Drug Type Insights (Revenue, USD Mn, 2026 - 2033)
- Metronidazole
- Paromomycin
- Tinidazole
- Iodoquinol
- Dehydroemetine
- Chloroquine phosphate
- Others
Distribution Channel Insights (Revenue, USD Mn, 2026 - 2033)
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Regional Insights (Revenue, USD Mn, 2026 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- U.K.
- Germany
- Italy
- France
- Russia
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- North Africa
- Central Africa
- South Africa
Key Players Insights
- Pfizer Inc.
- Impax Laboratories
- Lupin Pharmaceuticals, Inc.
- Sanofi
- Actelion Pharmaceuticals Ltd.
- Glenmark Pharmaceuticals
- Sun Pharmaceutical Industries Inc.
- Heritage Pharmaceuticals Inc.
- Mission Pharmacal Co.
- Novel Laboratories

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Product Approval
Collaboration/Merge/Acquisition
Regulatory Landscape
PEST Analysis
Porter's Five Forces Analysis
Epidemiology
Robust Pipeline Analysis

4. Global Amebiasis Treatment Market, By Drug Type, 2021 - 2033, (USD Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Metronidazole
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Paromomycin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Tinidazole
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Iodoquinol
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Dehydroemetine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Chloroquine phosphate
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)

5. Global Amebiasis Treatment Market, By Distribution Channel, 2021 - 2033, (USD Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)

6. Global Amebiasis Treatment Market, By Region, 2021 - 2033, (USD Million)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Million)
  - North Africa
  - Central Africa
  - South Africa

7. Competitive Landscape

Heat Map Analysis
Market Share Analysis
Company Profile
- Pfizer Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Impax Laboratories,
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Lupin Pharmaceuticals, Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Sanofi
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Actelion Pharmaceuticals Ltd.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Glenmark Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Sun Pharmaceutical Industries Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Heritage Pharmaceuticals Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Mission Pharmacal Co.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Novel Laboratories
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
  - Analyst Views